Nephro Care India Stock Price Analysis and Quick Research Report. Is Nephro Care India an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Nephro Care India. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nephro Care India has a PE ratio of 74.2343240304458 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nephro Care India has ROA of 8.162% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nephro Care India has a Current ratio of 2.0124.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nephro Care India has a ROE of 10.623%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Nephro Care India has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: Nephro Care India has reported revenue growth of 69.0406% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Nephro Care India for the current financial year is 12.7578962918549%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nephro Care India is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Nephro Care India is Rs 2.2072. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Nephro Care India in Ticker for free. Also, one can get the intrinsic value of Nephro Care India by using Valuation Calculators, which are available with a Finology ONE subscription. 

Nephro Care India FAQs

Q1. What is Nephro Care India share price today?
Ans: The current share price of Nephro Care India is Rs 163.85.

Q2. What is the market capitalisation of Nephro Care India?
Ans: Nephro Care India has a market capitalisation of Rs 270.129664 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Nephro Care India?
Ans: The PE ratio of Nephro Care India is 74.2343240304458 and the P/B ratio of Nephro Care India is 5.05061402643519, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Nephro Care India share?
Ans: The 52-week high share price of Nephro Care India is Rs 276, and the 52-week low share price of Nephro Care India is Rs 99.95.

Q5. Does Nephro Care India pay dividends?
Ans: Currently, Nephro Care India does not pay dividends. Dividend yield of Nephro Care India is around 0%.

Q6. What are the face value and book value of Nephro Care India shares?
Ans: The face value of Nephro Care India shares is Rs 10, while the book value per share of Nephro Care India is around Rs 32.4416. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Nephro Care India?
Ans: Nephro Care India has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Nephro Care India?
Ans: The ROE of Nephro Care India is 10.623% and ROCE of Nephro Care India is 14.4195%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Nephro Care India a good buy for the long term?
Ans: The Nephro Care India long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Nephro Care India undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Nephro Care India appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Nephro Care India’s financials?
Ans: You can review Nephro Care India’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.